Ahrens Brenton Karl

DirectorIterum Therapeutics plc (ITRM) · full profile →Form 4 · filed Sep 15, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$94K
Net Open-Market Flow
-$94K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2022Sell(S)15K$2.02$30K37K
Sep 14, 2022Sell(S)15K$2.10$32K52K
Sep 13, 2022Sell(S)15K$2.14$32K67K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-031172) within minutes of acceptance. Every field above traces to the original document. Verify it directly: